HomeNAUT • NASDAQ
Nautilus Biotechnology Inc
add
$0.77
4.92%
Pre-market:(5.51%)+0.042
$0.81
Closed: Jun 4, 4:00:06 AM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.84M | -12.79% |
Net income | -16.61M | 11.30% |
Net profit margin | — | — |
Earnings per share | -0.13 | 13.33% |
EBITDA | -18.38M | 12.86% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 138.81M | -23.46% |
Total assets | 227.69M | -21.12% |
Total liabilities | 33.26M | -15.07% |
Total equity | 194.44M | — |
Shares outstanding | 126.15M | — |
Price to book | 0.48 | — |
Return on assets | -20.03% | — |
Return on capital | -20.35% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -16.61M | 11.30% |
Cash from operations | -13.94M | 14.32% |
Cash from investing | 19.51M | -12.71% |
Cash from financing | 18.00K | -92.65% |
Net change in cash | 5.59M | -11.69% |
Free cash flow | -7.68M | 21.63% |
Previous close
$0.73
Day range
$0.73 - $0.79
Year range
$0.66 - $3.09
Market cap
97.10M USD
Avg Volume
184.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
134
